Insmed Inc (INSM)
25.25
+1.11
(+4.60%)
USD |
NASDAQ |
Apr 23, 15:17
Insmed Gross Profit Margin (Quarterly): 77.96% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 77.96% |
| September 30, 2023 | 78.87% |
| June 30, 2023 | 78.51% |
| March 31, 2023 | 78.79% |
| December 31, 2022 | 77.96% |
| September 30, 2022 | 80.11% |
| June 30, 2022 | 74.86% |
| March 31, 2022 | 77.04% |
| December 31, 2021 | 76.32% |
| September 30, 2021 | 78.22% |
| June 30, 2021 | 76.11% |
| March 31, 2021 | 75.52% |
| December 31, 2020 | 73.77% |
| September 30, 2020 | 75.66% |
| June 30, 2020 | 76.59% |
| March 31, 2020 | 77.11% |
| December 31, 2019 | 80.95% |
| September 30, 2019 | 83.45% |
| June 30, 2019 | 83.59% |
| March 31, 2019 | 81.05% |
| December 31, 2018 | 75.36% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
73.77%
Minimum
Dec 2020
83.59%
Maximum
Jun 2019
77.97%
Average
77.96%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| NeuroMetrix Inc | 64.35% |
| Intra-Cellular Therapies Inc | 91.86% |
| Rhythm Pharmaceuticals Inc | 86.66% |
| Amylyx Pharmaceuticals Inc | 91.37% |
| AN2 Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -51.57% |
| Return on Invested Capital | -75.46% |
| Profit Margin (Quarterly) | -222.3% |
| Operating Margin (Quarterly) | -194.2% |
| Return on Net Operating Assets | -180.6% |